Pharmaceutical

Radiopharm and AtomVie partner on radioantibody development

Radiopharm Theranostics (RAD) and AtomVie have announced a partnership for the development and manufacturing of 177Lu-BetaBart.

Oct 18, 2024 - 04:00
Radiopharm and AtomVie partner on radioantibody development
Radiopharm Theranostics (RAD) and AtomVie have announced a partnership for the development and manufacturing of 177Lu-BetaBart.
Read the original article

Tags:

Previous Article

bit.bio defends European patent for ‘novel’ opti-ox technology

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Ikena fires 35% of staff to funnel funds into clinical oncology programmes

Ikena fires 35% of staff to funnel funds into clinical ...

Jan 19, 2024

FDA greenlights first over-the-counter birth control pill

FDA greenlights first over-the-counter birth control pill

Jul 13, 2023

ASCO 2023: Research backs chemo-only approach for some rectal cancer patients

ASCO 2023: Research backs chemo-only approach for some ...

Jun 5, 2023